Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,191,369
+$27,416,633 QoQ
Shares Held
233,171
+53.4% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
5.40%
of 13F equity value
Holder Rank
#38
of 307 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2026CallValue
$5,123,552
CallShares
22,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. ASND ranks #1 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in ASND
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,191,369 | 233,171 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,123,552 | 22,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $34,774,736 | 152,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $37,889,549 | 177,685 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $28,889,279 | 145,311 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,274,740 | 221,754 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,132,727 | 186,916 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,212,806 | 52,392 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,552,271 | 90,766 | Shares | Defined | 2024-11-14 | |
| 2023-03-31 | $21,670,770 | 202,115 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||